These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24366432)

  • 21. Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives.
    Huerta Ángeles G; Nešporová K
    Carbohydr Polym; 2021 May; 259():117697. PubMed ID: 33673986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Non-Cross Linked Xeno-Free Hyaluronic Acid Solutions as Visco Elastic Biomaterials.
    Mohan SP; Palaniappan A
    J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 1):S673-S676. PubMed ID: 37654424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheological and cohesive properties of hyaluronic acid.
    Falcone SJ; Palmeri DM; Berg RA
    J Biomed Mater Res A; 2006 Mar; 76(4):721-8. PubMed ID: 16315193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of two host-guest associating hyaluronan derivatives.
    Soltés L; Mendichi R
    Biomed Chromatogr; 2003 Sep; 17(6):376-84. PubMed ID: 13680848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronic acid containing hydrogels for the reduction of protein adsorption.
    Van Beek M; Jones L; Sheardown H
    Biomaterials; 2008 Mar; 29(7):780-9. PubMed ID: 18023474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A complete hyaluronan hydrodynamic characterization using a size exclusion chromatography-triple detector array system during in vitro enzymatic degradation.
    La Gatta A; De Rosa M; Marzaioli I; Busico T; Schiraldi C
    Anal Biochem; 2010 Sep; 404(1):21-9. PubMed ID: 20399193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the visco-elastic properties of hyaluronic acid.
    Lázaro B; Alonso P; Rodriguez A; La Nuez M; Marzo F; Prieto JG
    Biorheology; 2018; 55(1):41-50. PubMed ID: 30320557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of ultrapure hyaluronic acid with different molecular weights on the healing of porcine full thickness skin wound].
    Jia C; Chen B; Arnold F
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jul; 12(4):197-200. PubMed ID: 10437065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results.
    Balazs EA
    Surg Technol Int; 2004; 12():278-89. PubMed ID: 15455338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlling Molecular Weight of Hyaluronic Acid Conjugated on Amine-rich Surface: Toward Better Multifunctional Biomaterials for Cardiovascular Implants.
    Li J; Wu F; Zhang K; He Z; Zou D; Luo X; Fan Y; Yang P; Zhao A; Huang N
    ACS Appl Mater Interfaces; 2017 Sep; 9(36):30343-30358. PubMed ID: 28836435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of posterior capsule opacification by hyaluronic acid in an ex vivo model.
    Chandler HL; Haeussler DJ; Gemensky-Metzler AJ; Wilkie DA; Lutz EA
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1835-45. PubMed ID: 22408013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low molecular weight hyaluronic acid effects on murine macrophage nitric oxide production.
    Lyle DB; Breger JC; Baeva LF; Shallcross JC; Durfor CN; Wang NS; Langone JJ
    J Biomed Mater Res A; 2010 Sep; 94(3):893-904. PubMed ID: 20336750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells.
    Masters KS; Shah DN; Leinwand LA; Anseth KS
    Biomaterials; 2005 May; 26(15):2517-25. PubMed ID: 15585254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of molecular mass determination of hyaluronic acid using SEC/MALLS and sedimentation equilibrium.
    Hokputsa S; Jumel K; Alexander C; Harding SE
    Eur Biophys J; 2003 Aug; 32(5):450-6. PubMed ID: 12698289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?
    Aviad AD; Houpt JB
    J Rheumatol; 1994 Feb; 21(2):297-301. PubMed ID: 8182640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of an Analytical Method for the Simultaneous Determination of Hyaluronic Acid Concentration and Molecular Weight by Size-Exclusion Chromatography.
    Suárez-Hernández LA; Camacho-Ruíz RM; Arriola-Guevara E; Padilla-Camberos E; Kirchmayr MR; Corona-González RI; Guatemala-Morales GM
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronan: pharmaceutical characterization and drug delivery.
    Liao YH; Jones SA; Forbes B; Martin GP; Brown MB
    Drug Deliv; 2005; 12(6):327-42. PubMed ID: 16253949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy study of two novel hyaluronic acid-based formulations for viscosupplementation therapy in an early osteoarthrosic rabbit model.
    Kaderli S; Viguier E; Watrelot-Virieux D; Roger T; Gurny R; Scapozza L; Möller M; Boulocher C; Jordan O
    Eur J Pharm Biopharm; 2015 Oct; 96():388-95. PubMed ID: 26369477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties.
    Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI
    Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of hyaluronan grafted with dodecanoic acid as a potential ophthalmic treatment.
    Huerta-Ángeles G; Ondreáš F; Brandejsová M; Kopecká K; Vagnerová H; Kulhánek J; Drmota T
    Carbohydr Polym; 2020 Oct; 246():116578. PubMed ID: 32747245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.